Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 1
2010 1
2011 1
2013 2
2014 1
2015 2
2016 1
2017 2
2019 1
2020 1
2021 2
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial.
Beghi E, Pupillo E, Bianchi E, Bonetto V, Luotti S, Pasetto L, Bendotti C, Tortarolo M, Sironi F, Camporeale L, Sherman AV, Paganoni S, Scognamiglio A, De Marchi F, Bongioanni P, Del Carratore R, Caponnetto C, Diamanti L, Martinelli D, Calvo A, Filosto M, Padovani A, Piccinelli SC, Ricci C, Dalla Giacoma S, De Angelis N, Inghilleri M, Spataro R, La Bella V, Logroscino G, Lunetta C, Tarlarini C, Mandrioli J, Martinelli I, Simonini C, Zucchi E, Monsurrò MR, Ricciardi D, Trojsi F, Riva N, Filippi M, Simone IL, Sorarù G, Spera C, Florio L, Messina S, Russo M, Siciliano G, Conte A, Saddi MV, Carboni N, Mazzini L; RNS60-ALS Study Group. Beghi E, et al. Eur J Neurol. 2023 Jan;30(1):69-86. doi: 10.1111/ene.15573. Epub 2022 Oct 7. Eur J Neurol. 2023. PMID: 36148821 Free PMC article. Clinical Trial.
3D bioprinted osteosarcoma model for experimental boron neutron capture therapy (BNCT) applications: Preliminary assessment.
Delgrosso E, Scocozza F, Cansolino L, Riva F, Conti M, Loi G, Auricchio F, Postuma I, Bortolussi S, Cobianchi L, Ferrari C. Delgrosso E, et al. Among authors: ferrari c. J Biomed Mater Res B Appl Biomater. 2023 Aug;111(8):1571-1580. doi: 10.1002/jbm.b.35255. Epub 2023 Apr 4. J Biomed Mater Res B Appl Biomater. 2023. PMID: 37014107
Multimodal evaluation of 19F-BPA internalization in pancreatic cancer cells for boron capture and proton therapy potential applications.
Ciardiello A, Altieri S, Ballarini F, Bocci V, Bortolussi S, Cansolino L, Carlotti D, Ciocca M, Faccini R, Facoetti A, Ferrari C, Ficcadenti L, Furfaro E, Giagu S, Iacoangeli F, Macioce G, Mancini-Terracciano C, Messina A, Milazzo L, Pacifico S, Piccolella S, Postuma I, Rotili D, Vercesi V, Voena C, Vulcano F, Capuani S. Ciardiello A, et al. Among authors: ferrari c. Phys Med. 2022 Feb;94:75-84. doi: 10.1016/j.ejmp.2021.12.011. Epub 2022 Jan 6. Phys Med. 2022. PMID: 34999515
Comparison of Photon Isoeffective Dose Models Based on In Vitro and In Vivo Radiobiological Experiments for Head and Neck Cancer Treated with BNCT.
Perotti Bernardini GF, Bortolussi S, Koivunoro H, Provenzano L, Ferrari C, Cansolino L, Postuma I, Carando DG, Kankaanranta L, Joensuu H, González SJ. Perotti Bernardini GF, et al. Among authors: ferrari c. Radiat Res. 2022 Aug 1;198(2):134-144. doi: 10.1667/RADE-21-00234.1. Radiat Res. 2022. PMID: 35504003
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway.
Tonon F, Cemazar M, Kamensek U, Zennaro C, Pozzato G, Caserta S, Ascione F, Grassi M, Guido S, Ferrari C, Cansolino L, Trotta F, Kuzmanov BG, Forte G, Martino F, Perrone F, Bomben R, Gattei V, Elvassore N, Murano E, Truong NH, Olson M, Farra R, Grassi G, Dapas B. Tonon F, et al. Among authors: ferrari c. Cancers (Basel). 2022 Mar 23;14(7):1630. doi: 10.3390/cancers14071630. Cancers (Basel). 2022. PMID: 35406401 Free PMC article.
20 results